Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Regen Biopharma, Inc./ 8-K

Current Report · 8-K

Regen Biopharma, Inc.

RGBPOTCEQUITYCurrent

Current Report

Filed Nov 29, 2024Accepted Nov 29, 2024, 1:05 AM ESTCIK 1589150Accession 0001493152-24-048090
View company →Permanent SEC source ↗
Share

Company context

Current securities

RGBPOTC · EQUITY · CurrentRGBPPOTC · PREFERRED · Current

Recent company filings

  1. 10-Q filingAug 17, 2026
  2. NT 10-Q filingAug 13, 2026
  3. Entry into a Material Definitive Agreement · Changes in Registrant's Certifying Accountant · Other EventsJul 15, 2026
  4. 10-Q filingMay 14, 2026
  5. Unregistered Sales of Equity SecuritiesMar 4, 2026